Literature DB >> 7786021

Nitric oxide protects against alkyl peroxide-mediated cytotoxicity: further insights into the role nitric oxide plays in oxidative stress.

D A Wink1, J A Cook, M C Krishna, I Hanbauer, W DeGraff, J Gamson, J B Mitchell.   

Abstract

Endogenously formed nitric oxide (NO) possesses diverse properties such as regulating physiological functions, exerting specific toxic effects, and protecting against various toxic substances. Recent studies suggest that in the presence of reactive oxygen species, NO can serve as an antioxidant. We show here that NO delivered from the NO donor compound, PAPA/NO (NH2(C3H6)(N[N(O)NO](C3H7)), protects Chinese hamster V79 lung fibroblasts from the cytotoxicity of t-butyl hydroperoxide and cumene hydroperoxide. In contrast, the other end products of PAPA/NO degradation in aqueous solution, NH2(C3H6)NH(C3H7) and nitrite, did not protect. The NONOate DEA/NO releases NO six times faster than PAPA/NO, yet did not afford protection, which implies that NO must be present throughout the alkyl hydroperoxide exposure. Measurements of NO concentrations released from PAPA/NO suggest that micromolar levels protect against cytotoxicity induced by alkyl hydroperoxides. These findings demonstrate that the flux of NO sustained over the duration of the peroxide exposure determines protection and not the total of NO delivered. These results suggest that concentrations of NO produced in the microenvironment of endothelial cells are high enough to protect cells from Fenton-type-mediated toxicity and support the premise that NO may exert a salutary effect in certain diseases associated with membrane damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7786021     DOI: 10.1006/abbi.1995.1310

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  NO-mediated cytoprotection: instant adaptation to oxidative stress in bacteria.

Authors:  Ivan Gusarov; Evgeny Nudler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

Review 2.  Adventures in vascular biology: a tale of two mediators.

Authors:  S Moncada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

3.  Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryls that spare the enzyme iron center.

Authors:  D M Kuhn; R Arthur
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

Review 4.  Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.

Authors:  Paolo Cassano; Samuel R Petrie; Michael R Hamblin; Theodore A Henderson; Dan V Iosifescu
Journal:  Neurophotonics       Date:  2016-03-04       Impact factor: 3.593

5.  Radiation sensitisation by nitric oxide releasing agents.

Authors:  J B Mitchell; J A Cook; M C Krishna; W DeGraff; J Gamson; J Fisher; D Christodoulou; D A Wink
Journal:  Br J Cancer Suppl       Date:  1996-07

6.  IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner.

Authors:  S Chikano; K Sawada; T Shimoyama; S I Kashiwamura; A Sugihara; K Sekikawa; N Terada; K Nakanishi; H Okamura
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

7.  Nitric oxide enhancement of melphalan-induced cytotoxicity.

Authors:  J A Cook; M C Krishna; R Pacelli; W DeGraff; J Liebmann; J B Mitchell; A Russo; D A Wink
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Inhaled nitric oxide alleviates hyperoxia suppressed phosphatidylcholine synthesis in endotoxin-induced injury in mature rat lungs.

Authors:  Xiaohui Gong; Chunbao Guo; Shibing Huang; Bo Sun
Journal:  Respir Res       Date:  2006-01-11

Review 9.  The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?

Authors:  Frederico Vieira; Marjorie Makoni; Edgardo Szyld; Krishnamurthy Sekar
Journal:  Front Pediatr       Date:  2021-03-31       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.